Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $0.60 Analyst target: $42.67 Upside: 7011.67%
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.